China is losing the intellectual property rights of traditional Chinese medicine.
Paul Beards, a world-renowned economist, once predicted that by 20 10, health-related industries will bring 1 trillion dollars of annual income to the American economy, which comes from products and services that make people healthier and more beautiful, delay aging or prevent diseases, and so on.
Twenty years ago, the health industry did not exist, but today, the income of the health industry reaches 200 billion US dollars, which is equivalent to half of the income of the entire American automobile industry. From 2000 to 20 10, the consumption of health industry will increase from 200 billion to 1 trillion dollars, a full five-fold increase. China has a population of1300 million. Experts predict that the consumption of health care products will continue to increase from the current 2.5% of GDP, thus becoming a new economic growth point. Therefore, there is a huge market for health care products in China.
Traditional Chinese medicine has a cultural background of five thousand years. According to records, Chinese people began to use "health food" as early as more than 1000 years ago in the Eastern Han Dynasty. Therefore, China people have an absolute advantage in traditional Chinese medicine preparations.
However, in this tide of health industry, there is no well-known brand of traditional Chinese medicine at home and abroad in China.
China's traditional Chinese medicine health care products have the genes to create a world brand. But in the face of strong competitors, we must take the road of China-oriented health industry.
At present, the trade volume of traditional Chinese medicine in the international market has exceeded 40 billion dollars, and it is increasing at the rate of 10% every year. However, the export trade of traditional Chinese medicine in China only accounts for less than 3% of the total world herbal medicine trade. Chinese medicine enterprises in Japan, South Korea, Southeast Asia and some European countries buy raw materials from China at low prices, rough process them locally, transport them back to China for refining, extract preparations and make them into capsules, tablets and granules for westerners to use. They not only occupy the international market, but also sell them back to China market at high prices, and now account for13 of the Chinese patent medicine market in China. However, China imports more than US$ 6,543.8+billion of foreign traditional Chinese medicines from Japan, South Korea, Southeast Asia and Western Europe every year. On the other hand, although there are only 265,438+00 kinds of Chinese medicine preparations in Japan, and all prescriptions and raw materials come from China, its share in the international market has reached 80%.
In order to change the backward situation of traditional Chinese medicine production in China, it is understandable that some localities and units in China actively seek international cooperation and introduce foreign capital and advanced production technology. However, in order to achieve this goal, some people are short-sighted and eager for quick success, ignoring the great value of Chinese medicine prescriptions as intangible assets, and handing over their own independent intellectual property rights-Chinese medicine prescriptions to foreign businessmen, making Chinese medicine production in a more unfavorable position in international competition.
China also has a large number of TCM secret recipes and folk remedies. Although they have achieved certain effects in long-term clinical practice of traditional Chinese medicine, they are still circulated in the form of over-the-counter drugs because of the low level of scientific research and analysis separation technology. Many foreign businessmen are stepping up research and analysis, and even applied for many patents first, which makes the loss of intellectual property rights of national treasure Chinese medicine amazing.
At the same time, if we can't really understand the operating rules of the health care products market and accurately grasp the market context, it is also very easy to encounter Waterloo. Therefore, in the past ten years, many large enterprises have entered the health care products and ended in failure. Daguide Company adheres to the road of healthy industry with China characteristics, and takes "promoting national culture, establishing national brands and realizing a balanced life" as its corporate mission. Put forward the management slogan "My world is created by me", based on China, facing the world, aiming at smallness, and developing steadily.
In order to enter the international market in an all-round way, China traditional Chinese medicine must be in line with international standards and realize the modernization of traditional Chinese medicine, first of all, the modernization of research and development. Therefore, it is necessary to establish a standardized planting base of traditional Chinese medicine, adopt advanced production technology and modern dosage forms, establish quality standards and norms of traditional Chinese medicine, improve quality standards of traditional Chinese medicine, strengthen pharmacological and toxicological research of traditional Chinese medicine, attach importance to clinical trials of traditional Chinese medicine, and formulate production management norms of traditional Chinese medicine. In this process, we must vigorously strengthen the research and protection of intellectual property rights of traditional Chinese medicine. Otherwise, China's traditional Chinese medicine industry will become an industry without independent intellectual property rights, losing the right to exist, and the consequences will be unimaginable.